Tevogen Bio Holdings, Inc. (TVGN)
7.32
+0.35
(+5.02%)
USD |
NASDAQ |
May 13, 11:08
Tevogen Bio Holdings Shareholders Equity (Quarterly) : -8.235M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Agenus, Inc. | -221.22M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
| Anika Therapeutics, Inc. | 133.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.383M |
| Total Liabilities (Quarterly) | 12.62M |
| Debt to Equity Ratio | -0.911 |
| Current Ratio | 0.2178 |
| Net Debt Paydown Yield | -1.36% |